ALLK - Allakos Inc.
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 72.00 |
| Open | 73.39 |
| Bid | 75.79 x 900 |
| Ask | 76.26 x 800 |
| Day's Range | 72.90 - 78.05 |
| 52 Week Range | 30.32 - 139.99 |
| Volume | 148,784 |
| Avg. Volume | 307,166 |
| Market Cap | 3.715B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.00 |
| Earnings Date | Aug 03, 2020 - Aug 07, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 82.00 |
Fair Value
Related Research
- Insider Monkey
Hedge Funds Dropped The Ball On Allakos Inc. (ALLK)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
- ACCESSWIRE
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of the Following Companies: Allakos, Inc. (Nasdaq - ALLK), Enphase Energy, Inc. (Nasdaq - ENPH), MoSys, Inc. (Nasdaq - MOSY)
BALA CYNWYD, PA / ACCESSWIRE / June 16, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims regarding the following companies for possible breaches of fiduciary ...
- GlobeNewswire
Allakos Initiates Patient Recruitment for AK002 Registrational Studies
-- Phase 3 study in eosinophilic gastritis and/or eosinophilic duodenitis and Phase 2/3 study in eosinophilic esophagitis -- -- Top-line safety and efficacy results from.
- GlobeNewswire
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020
REDWOOD CITY, Calif., May 21, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.
- Zacks
Why Allakos (ALLK) Stock Might be a Great Pick
Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Zacks
All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy
Allakos Inc (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- Newsfile
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - May 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. (NASDAQ: ALLK) ("Allakos" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ...
- ACCESSWIRE
ALLK DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020
NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allakos Inc. ("Allakos" or the Company") ...
- Business Wire
ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm – ALLK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the "Class Period") of the important May 11, 2020 lead plaintiff deadline in the securities class action commenced by the firm. The lawsuit seeks to recover damages for Allakos investors under the federal securities laws.
- GlobeNewswire
Allakos Announces a Presentation of Antolimab in Patients with Severe Allergic Conjunctivitis at the 2020 ASCRS Virtual Annual Meeting
REDWOOD CITY, Calif., May 11, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.
- GlobeNewswire
Allakos Reports First Quarter 2020 Financial Results
REDWOOD CITY, Calif., May 11, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.
- ACCESSWIRE
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Allakos (ALLK) Investors: Important Application Deadline Tomorrow, Investors with Losses Should Contact its Attorneys Now
SAN FRANCISCO, CA / ACCESSWIRE / May 10, 2020 / Hagens Berman urges Allakos Inc. ( NASDAQ:ALLK ) investors who have suffered significant losses to submit their losses now . Tomorrow is the lead plaintiff ...
- ACCESSWIRE
ALLK FINAL MONDAY DEADLINE, ROSEN, FIRST FILING FIRM AND GLOBAL COUNSEL, Encourages Allakos Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action Seeking Recovery of Investor losses - ALLK
NEW YORK, NY / ACCESSWIRE / May 10, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ:ALLK) between August 5, 2019 through December ...
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK
NEW YORK, NY / ACCESSWIRE / May 10, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Allakos Inc. ("Allakos" or the "Company") (NASDAQ:ALLK). Such investors are ...
ACCESSWIREFINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 10, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.
- GlobeNewswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 2-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm Immediately
SAN FRANCISCO, May 09, 2020 -- Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact.
- GlobeNewswire
ALLAKOS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allakos Inc. (“Allakos” or the “Company”) (ALLK) of the May 11, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
- Newsfile
2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - May 9, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, ...
- ACCESSWIRE
FINAL DEADLINE MAY 11: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 9, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.
- GlobeNewswire
Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Allakos, Inc. - ALLK
Safirstein Metcalf LLP announces that a class action has been filed on behalf of investors that purchased the securities of Allakos Inc. (“Allakos” or the “Company”) (ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). If you purchased Allakos securities during the Class Period and would like more information about the shareholder class action, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com. If you wish to serve as a lead plaintiff, you must move the Court no later than May 11, 2020.
- ACCESSWIRE
FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 8, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.
- ACCESSWIRE
ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 11, 2020
NEW YORK, NY / ACCESSWIRE / May 8, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allakos Inc. ("Allakos" or the Company") ...
- GlobeNewswire
ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors that only 3 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Allakos Inc. (“Allakos” or the “Company”) (ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities and Exchange Act of 1934. If you purchased Allakos securities, and/or would like to discuss your legal rights and options please visit Allakos Shareholder Class Action or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.
- GlobeNewswire
ALLAKOS FINAL DEADLINE, ROSEN, A TOP RANKED FIRM, Encourages Allakos Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action First Filed by Firm Seeking Recovery of Investor losses – ALLK
NEW YORK, May 08, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through.
- Newsfile
Allakos Class Action Reminder: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - May 8, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allakos Inc. ("Allakos" or the "Company") (NASDAQ:ALLK) of the May 11, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Allakos stock or options between August 5, 2019 and December 17, ...
